Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K021944
    Date Cleared
    2003-05-14

    (335 days)

    Product Code
    Regulation Number
    862.3220
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Cozart Bioscience EIA Cotinine Urine Kit is intended for laboratory based testing in clinical and analytical laboratories and for insurance assessment. It provides qualitative screening results for Cotinine in human urine at a cut-off concentration of 500ng/ml. The Cozart EIA Cotinine Urine Kit acts as an aid in the detection of cotinine after use of tobacco products or other products containing nicotine.

    This assay is for professional use only and provides only a preliminary analytical test result. Clinical consideration and professional judgement must be applied to any drug of abuse test result, particularly in evaluating a preliminary positive result. In order to obtain a more confirmed analytical result a more specific alternative chemical method is needed. Gas Chromatography/Mass Spectrometry (GC/MS) is the preferred confirmatory method.

    Device Description

    The Cozart EIA Cotinine Urine Kit test is a competitive ELISA for the detection of Cotinine in human urine. The kit supplies the following reagents - a microtitre plate coated with antibody, enzyme conjugate reagent, wash buffer, substrate solution, stop solution and four calibrators (0, 50, 500 and 5000ng/ml Cotinine in human urine).

    AI/ML Overview

    Here's a breakdown of the acceptance criteria and the study details for the Cozart EIA Cotinine Urine Kit, based on the provided text:

    Acceptance Criteria and Device Performance

    ParameterAcceptance Criteria (Implied by Predicate/Performance Claims)Reported Device Performance (Cozart EIA Cotinine Urine Kit)
    Intended UseQualitative test for Cotinine in human urine with a 500ng/ml cutoff. Recommendation for GC/MS confirmation.Qualitative test for Cotinine in human urine with a 500ng/ml cutoff. Recommendation for GC/MS confirmation.
    Method ComparisonHigh agreement with GC/MS for positive and negative samples.98% agreement for positive results (56/57), 100% agreement for negative results (38/38) with GC/MS (based on 95 samples).
    PrecisionCV (%) for the assay should be acceptable for qualitative ELISA (e.g., <10% for internal controls, <11% for total precision).CVs less than 10% for internal controls; total precision CVs less than 11%.
    SensitivityA low detection limit for cotinine.1.2 ng/ml
    SpecificityMinimal cross-reactivity with common interferents.Only nicotine cross-reacted (at 10,000 ng/ml) out of 28 tested substances. No interference observed with pH, specific gravity, ascorbic acid, or protein.
    Cutoff ConcentrationProper differentiation around the 500ng/mL cutoff.Successfully differentiated between 375ng/mL (higher absorbance) and 625ng/mL (lower absorbance) compared to the 500ng/mL cutoff calibrator.
    Sample StabilitySamples should remain stable for a reasonable period under various storage conditions.Stable for 21 days at 2-8°C, 25°C, and 37°C. For longer storage, freeze at -20°C.
    Stopped Assay StabilityFinished assay should be stable for a practical reading window.Must be read within 15 minutes at 450nm.
    Assay DriftMinimal drift with variation in sample addition time.Little change observed when samples added within 25 minutes.

    Study Details

    1. Sample Size Used for the Test Set and Data Provenance:

      • Sample Size: 95 urine specimens.
      • Data Provenance: The samples were collected from drug dependency units in Coventry and Warwick, UK. The data is retrospective, as the samples were collected and then tested.
    2. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications:

      • The ground truth was established by Gas Chromatography/Mass Spectrometry (GC/MS). While GC/MS is an analytical method rather than an "expert," the results were performed by the Analytical Services Laboratory at Cozart Bioscience Ltd. The qualifications of the personnel performing these analyses are not explicitly stated but are presumed to be qualified laboratory staff.
    3. Adjudication Method for the Test Set:

      • Not applicable in the traditional sense, as the ground truth was established by a single, definitive analytical method (GC/MS). The Cozart EIA result was compared directly against the GC/MS result for agreement. There was no "expert consensus" or "adjudication" between multiple interpretations of the ground truth.
    4. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study was done:

      • No, an MRMC comparative effectiveness study was not done. The study focused on the performance of the Cozart EIA Cotinine Urine Kit against a gold standard analytical method (GC/MS) rather than comparing different human readers or human readers with and without AI assistance.
    5. If a Standalone Study (algorithm only without human-in-the-loop performance) was done:

      • Yes, a standalone study was performed. The Cozart EIA Cotinine Urine Kit is a laboratory-based immunoassay kit, and its performance was evaluated intrinsically as a diagnostic device, without human interpretation influencing the primary result generated by the kit itself. The results are read spectrophotometrically, which is an objective measurement.
    6. The Type of Ground Truth Used:

      • The ground truth used was Gas Chromatography/Mass Spectrometry (GC/MS), which is considered a highly specific and sensitive reference method for cotinine detection (often referred to as the "gold standard" in toxicology).
    7. The Sample Size for the Training Set:

      • The document does not explicitly mention a separate "training set" for the Cozart EIA Cotinine Urine Kit. For an immunoassay kit like this, the development process involves reagent formulation and optimization, calibration, and validation. The "training" in this context would typically refer to the internal development and optimization of the assay parameters, not a separate data set for a machine learning algorithm. The provided "Method Comparison" data is for the test set (validation of the final product).
    8. How the Ground Truth for the Training Set Was Established:

      • As no explicit "training set" is mentioned in the context of typical machine learning models, the concept of establishing ground truth for it doesn't directly apply here. For the development and optimization of the assay itself, known concentrations of cotinine (calibrators) and controls would have been used. The GC/MS method would likely have also been used during the R&D phase to define the kit's performance characteristics and optimize its components (e.g., antibody binding, enzyme conjugates, cutoff values).
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1